Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies — Kamal Awad (2021) | RDL Network
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Article 2021 en
Authors
KA
Kamal Awad
MM
Maged Mohammed
MZ
Mahmoud Zaki
Abstract
1 min read
Statin therapy in older people (aged ≥ 65 years) without CVD was associated with a 14%, 20%, and 15% lower risk of all-cause mortality, CVD death, and stroke, respectively. The beneficial association with the risk of all-cause mortality remained significant even at higher ages (> 75 years old), in both men and women, and in individuals with DM, but not in those without DM. These observational findings support the need for trials to test the benefits of statins in those above 75 years of age.
Kamal Awad, M Mohammed, Mahmoud Zaki, Abdelrahman Ibrahim Abushouk, Professor Gregory Lip, Michael J. Blaha, Carl J. Lavie, Peter P. Tóth, J. Wouter Jukema, Naveed Sattar, Maciej Banach
Sylvia E. Choi, Tommaso Bucci, Jiayi Huang, Kai‐Hang Yiu, Christopher Tze‐Wei Tsang, Kui Kai Lau, Andrew Hill, Greg Irving, Professor Gregory Lip, Azmil H. Abdul‐Rahim
Discussion(0)
No comments yet. Be the first to comment.